Sunshine Biopharma - SBFM Operating Margin

Corporate company logo of sunshinebiopharma.com (SBFM)

Sunshine Biopharma operates within the stable US jurisdiction, avoiding sanctions due to the humanitarian status of its developments. The operating margin breakdown on the GURU.Markets terminal chart demonstrates business efficiency, where -16.80 captures the magnitude of this parameter. Revenues are based on the sale of dietary supplements and the development of pancreatic cancer therapies. Innovations are accelerating through robotic bio-screening, which automates the search for chemical compounds.

Sunshine Biopharma Inc. (SBFM): Return on Sales by Operating Profit from 07/04/2022 to 11/19/2026

Sunshine Biopharma - analytical breakdowns and key metrics (SBFM)

- share price and consensus valuation forecast:
Summary company analysis:Sunshine Biopharma Inc., SBFM
Brand item of Sunshine Biopharma Inc.

For Sunshine Biopharma (SBFM), changes in operating margin demonstrate the biopharmaceutical business's ability to transform the success of a single molecule into scalable profit amid fixed R&D costs. This metric is calculated as the ratio of operating profit to revenue, measuring the efficiency of core production before accounting for financial obligations and taxes, which allows investors to assess the real profitability and sustainability of the business model.

Competitor analysis

Operating Profitability BeiGene Ltd|Halozyme Therapeutics - Operating Profit Margin|Operating Sales Margin RVMD (Revolution Medicines Corp)|Operating Profit Ratio AAPG|Operating Profitability CG Oncology Therapeutics CGON|Operating Profit Rate URGN|BCAX: Operating Sales Margin|PSNL: Operating Profitability|Erasca (ERAS) - Operating Profitability|DCTH - Profitability of Operations|YMAB (Y-mAbs Corp) - Operating Margin|Operating Sales Margin Aura Biosciences (AURA)|Operating Profitability Candel Therapeutics Inc. (CADL)|Operating Sales Margin Accuray, Inc. ARAY|Operating Profitability sellaslifesciences.com SLS|Operating Profit Rate ACTU|CTOR - Operating Profitability|Profitability of Operations tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Operating Profitability|FATE: Operating Profit Ratio|WHWK (Aadi Bioscience, Inc.) - Operating Margin|TCRX (TScan Therapeutics) - Operating Profit Ratio|Operating Profitability Champions Oncology (CSBR)|Profitability of Operations XBiotech USA|Operating Profitability CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Operating Return on Sales|RADX - Operating Profitability|ARTV - Operating Margin|Adlai Nortye Ltd (ANL) - Operating Profitability|Veru Pharma - Operating Profit Rate|Operating Profitability Tempest Therapeutics Corp|Return on Sales by Operating Profit XLO (Xilio Therapeutics, Inc.)|Operating Margin RENB|MURA (Mural Oncology) - Operating Profit Rate|Operating Margin KAPA (Kairos Pharma Ltd)|OKUR: Return on Sales by Operating Profit|GDTC: Operating Sales Margin|CRIS - Operating Margin|APLM: Operating Margin|Operating Return on Sales tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Operating Margin|Operating Margin Genprex Inc.|Operating Margin CLDI|Xenetic Biosciences, Inc. - Return on Sales by Operating Profit|Operating Profitability Salarius Pharmaceuticals SLRX|Operating Margin purple-biotech.com PPBT|AONC - Operating Profitability|BGNE: Operating Profitability|CKPT: Operating Margin|Elevation Oncology - Operating Profit Rate|ICAD (iCAD) - Operating Margin|IKNA: Operating Profit Rate|Operating Profitability Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Operating Profit Rate|Operating Profitability MorphoSys Corporation MOR|NAYA: Return on Sales by Operating Profit|Ascentage Pharma Group International - Operating Margin